Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 254-259, January 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, S.
Right arrow Articles by Suzuki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, S.
Right arrow Articles by Suzuki, T.

Possible Mechanism of Sudan III-induced Prevention of Chemical Carcinogenesis in Rats

Shoichi Fujita1, Takashi Matsunaga, Yasuhiro Masubuchi and Tokuji Suzuki

Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, 1-33 Yayoicho, Chiba, Japan 260

The effect of treatment of rats with Sudan III on the ability of the liver to transform benzo(a)pyrene (BP) to a mutagen was investigated to elucidate a possible mechanism of the Sudan III-induced prevention of chemical carcinogenesis (Huggins et al., Proc. Natl. Acad. Sci., 75: 4524–4527, 1978) using a modified Ames mutagenesis test system. Preincubation of BP with liver 9000 x g supernatant (S-9) from rats treated with Sudan III markedly increased the mutagenicity of BP in the conventional Ames method. The increase in number of revertant colonies was proportional to the aryl hydrocarbon hydroxylase activity of the S-9 fractions used (r > 0.9). This azo dye was found to induce both cytochrome P-448 which is an activating enzyme of procarcinogens and the activities of UDP glucuronyl transferase and glutathione-S-transferase (GST), which are detoxifying enzymes of active carcinogenic intermediates. The addition of anti-cytochrome P-448 antibody or the cofactors for UDP glucuronyl transferase and glutathione-S-transferase to the liver S-9 preincubation mixture with BP caused a marked decrease in BP mutagenicity when liver S-9 fractions from Sudan III-treated rats were used. The decrease obtained by the addition of the cofactors was proportional to the induced levels of the UDP glucuronyl transferase or glutathione-S-transferase. It was concluded that Sudan III-induced prevention of chemical carcinogenesis is due to an accelerated elimination of the carcinogen by the induction of both cytochrome P-448 and detoxifying enzymes with a limited increase in levels of active metabolic intermediates.

1 To whom requests for reprints should be addressed.

Received 5/16/86. Revised 7/14/87. Revised 9/29/87. Accepted 10/ 5/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.